HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Genetic defect of the hyperbilirubinemic Gunn rat, a model for Crigler-Najjar syndrome type I].

Abstract
The hyperbilirubinemic Gunn rat lacks hepatic UDP-glucuronosyltransferase (UDPGT) activity toward bilirubin and has been used as an animal model for human Crigler-Najjar syndrome type I. Rat liver bilirubin UDPGT cDNA was isolated. The cDNA shared an identical 913-bp sequence (corresponding to the C-terminal 247 amino acid residues) with that for phenol UDPGT whose activity was also deficient in the Gunn rat. The bilirubin UDPGT gene was mapped at the position of 37 on mouse chromosome 1 by analyzing restriction endonuclease fragment length variations using the rat bilirubin UDPGT cDNA as a probe. The genetic defect of bilirubin UDPGT in the mutant rat was proved to be a -1 frameshift mutation. The mutation was found not only to be located in the region where the cDNA for bilirubin UDPGT shared the identical sequence with that for phenol UDPGT but also to occur in the same position in the two cDNAs from the mutant.
AuthorsH Sato, S Aono, O Koiwai
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 51 Issue 2 Pg. 501-6 (Feb 1993) ISSN: 0047-1852 [Print] Japan
PMID8096554 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • DNA Probes
  • DNA
  • Glucuronosyltransferase
Topics
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Chromosome Mapping
  • Crigler-Najjar Syndrome (genetics)
  • DNA (isolation & purification)
  • DNA Probes
  • Disease Models, Animal
  • Glucuronosyltransferase (chemistry, deficiency, genetics)
  • Humans
  • Molecular Sequence Data
  • Mutation
  • Polymorphism, Restriction Fragment Length
  • Rats
  • Rats, Gunn

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: